Dabigatran in atrial fibrillation

4th April 2012 by Louise Hudman

This guideline lays out the criteria for the use of Dabigatran, a thrombin inhibitor.

It can be considered as an alternative to warfarin in non-valvular AF if at least one of the following applies:

  • Previous CVA / TIA / systemic embolism
  • LV ejection fraction < 40%
  • Heart Failure NYHA II or above
  • ≥ 75
  • ≥ 65 + DM or coronary artery disease or hypertension

It is much more expensive than warfarin, though at higher doses is more effective at reducing stroke. Its major benefits are in not having so many food and drug interactions and not needing monitoring. We will need to wait to see how this will be used locally.

Read for free

Sign up to access everything.

Free trial

Login

Already a member? Login to view this content.

Login

"I started using LocumDeck as one of our locums used it. It was easy to see her availability and when bookings are made I get confirmation of the booking and can view them on the calendar too. When invoices are sent, I can see it on the site, and digitally sign the pension form (this is one of the best bits!). It would be good if all locums used it, as then it would be so much easier for me to track my bookings and check their availability without emailing or texting them, waiting for a reply and then emailing back to confirm. It’s a great place for their documents to sit also. I can access it from home or my mobile which is useful as when I am not in surgery is when I usually need a locum!"

Debbie, Practice Manager in St Ives

See the full list of features within our NASGP membership plans

Membership